mefruside has been researched along with Cancer of Prostate in 1 studies
Mefruside: A benzene-sulfonamide-furan. It is used as a diuretic that affects the concentrating ability of the KIDNEY, increases SODIUM CHLORIDE excretion, but may not spare POTASSIUM. It inhibits CARBONIC ANHYDRASES and may increase the blood URIC ACID level.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartsch, W | 1 |
| Horst, HJ | 1 |
| Becker, H | 1 |
| Nehse, G | 1 |
1 trial available for mefruside and Cancer of Prostate
| Article | Year |
|---|---|
Sex hormone binding globulin binding capacity, testosterone, 5alpha-dihydrotestosterone, oestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormonal treatment.
Topics: Chorionic Gonadotropin; Clinical Trials as Topic; Cyproterone; Diethylstilbestrol; Dihydrotestostero | 1977 |